CHAMGAP
APPROVEDReviewed and approved by the Chamgap Editorial Team (2026-07-23). The draft was written by AI, the existence of all 3 cited sources was verified at the original page, and the verdict passed blind grading and adversarial audit. Methodology v0.6.
Verdict No. 1330 · Search date 2026-07-23 · Methodology v0.6

Topical NAD+ serum,
does it really help with Reduced facial wrinkles and improved elasticity and skin aging through increased cellular energy?

30-Second Summary
?
Evidence Grade ? · Safety unknown
Direct topical NAD+ serum has not yet demonstrated wrinkle or elasticity benefits in a human efficacy trial
What the
research shows
A single-ingredient topical NAD+ serum is rated ? because no human efficacy literature shows that it increases facial skin cellular energy or improves wrinkles, elasticity, or skin aging. A 2026 study evaluated NAD+ in a specialized ion-coupled carrier in cells, porcine skin, and ex vivo human skin explants rather than wrinkles or elasticity in actual users. Topical NR precursor evidence is a manufacturer-led non-peer-reviewed preprint limited to acute moisturization, transepidermal water loss, and smoothness. Neither is an independent long-term human trial of direct NAD+ serum, so the score is null.
What the
ads claim
Marketing converts the cellular role of NAD+ in energy metabolism into instant topical energy charging, collagen regeneration, and wrinkle reversal. Results from precursors, delivery systems, and combinations may be presented as if they proved a direct NAD+ serum.
*

Useful facts when choosing a product

  • NAD+ itself, precursors such as NR, NMN, and niacinamide, and multi-ingredient products marketed as NAD-boosting are different ingredients and evidence tracks.
  • Free NAD+ is hydrophilic and has limited passive passage through the stratum corneum, prompting delivery-system research; actual delivery must be verified for each marketed formulation.
  • NAD+ content, stability, degradation products, and intradermal delivery may vary by cosmetic formulation, and no standardized consumer test establishes increased skin cellular energy.
  • Serious harm is not established, but solvents, fragrance, preservatives, and other finished-product ingredients can cause stinging, redness, or contact dermatitis; discontinue use if irritation develops.
Gap Measurement · Verdict 1330 · ?
What advertising claims
What independent, higher-quality research supports
△ GAP
01

What the research actually shows

Kang and colleagues reported that an ion-coupled NAD+ transfersome, ICoN, penetrated porcine and human skin explants better than free NAD+ and changed NAD+, mitochondrial, and senescence-related markers in cells and explants. The human skin was ex vivo, not a trial in users. A 2026 preprint by Idoine and colleagues assessed topical NR irritation and sensitization and, in 31-participant single-application studies, hydration, transepidermal water loss, and smoothness over eight hours. NR is not NAD+ itself, and long-term wrinkles and elasticity were not measured. A broad clinical review of NAD+ aging biology likewise describes human evidence as concentrated in oral precursors and other conditions and calls for adequately powered trials with meaningful endpoints.

02

Why this is classified as ?

No repeated-use human efficacy trial of a direct single-ingredient topical NAD+ serum has evaluated wrinkles, elasticity, or skin aging. A skin-explant delivery study and an acute NR hydration preprint concern different stages, ingredients, and endpoints, producing ? with a null score.

Counterpoint. Mechanistic plausibility is worth studying, but consumers should distinguish established wrinkle improvement from laboratory NAD+ biology. Sunscreen and evidence-based retinoids belong to separate evidence tracks.

Rejudgment record. Cross-check applied — Applied ? for absence of human efficacy literature because no independent intervention has tested a direct single-ingredient topical NAD+ serum for facial skin energy, wrinkles, elasticity, or skin aging, while available evidence is limited to delivery-platform skin explants and acute testing of the different precursor NR

Sub-claim grades by effect

This ingredient is marketed for several effects. A single overall grade blends strong and weak claims together, so each effect is graded separately here. The overall grade reflects the strongest disconfirming or core claim.

Effect (sub-claim)GradeBasis
Reduced facial wrinkles?No repeated-use human wrinkle trial exists for a direct single-ingredient NAD+ serum.
Improved skin elasticity?No direct topical NAD+ intervention has measured elasticity in living users.
Improved skin aging through increased cellular energy?Only cellular and skin-explant mechanistic signals exist, with no trial jointly verifying NAD+ or ATP and clinical aging in user skin.

Cross-check — Codex and Claude

This verdict was drafted by Codex through literature review and source-existence checks, cross-checked through blind grading and adversarial audit, and settled by reapplying the methodology boundary rules. Cases with split grades were resolved through rejudgment.
03

Evidence Table

StudyDesignSampleFundingEndpointResultWeight
Kang S et al. 2026 ICoNPreclinical cellular, porcine-skin, and ex vivo human-skin delivery and senescence-marker study0The publication's affiliations and conflicts require consideration for product translationIntradermal NAD+ delivery, mitochondrial function, and senescence markersICoN improved penetration and tissue markers over free NAD+, but did not measure wrinkles or elasticity in users.Precedes direct human efficacy
Idoine R et al. 2026 topical NR preprintNon-peer-reviewed human irritation, sensitization, and single-application acute cosmetic assessment31Led by authors affiliated with ChromaDex/Niagen BioscienceIrritation, sensitization, eight-hour hydration, TEWL, and smoothnessTopical NR was generally nonirritating and showed acute hydration and barrier signals, but it was not a trial of NAD+ itself, wrinkles, or elasticity.Adjacent evidence on a different precursor and acute endpoints
Bhasin S et al. 2023 reviewCritical review of NAD+ aging biology and clinical pharmacologyAcademic reviewNAD+ augmentation and clinical outcomes in age-related conditionsEarly human signals exist, but adequately powered randomized trials with meaningful endpoints remain necessary.Confirms the direct topical-serum evidence gap
§

Receipt — 3 References

All 3 cited sources were verified for existence at the original page (as of 2026-07-23).

Kang S, Wei S, Koo BI, et al. Ion-coupled transfersome complexes for enhanced transdermal NAD+ repletion and mitigation of cellular senescence signatures. Mater Today Bio. 2026;38:103218. PMID: 42170234. PMCID: PMC13188140. DOI: 10.1016/j.mtbio.2026.103218.
checked
Idoine R, Amini-Nik S, Mavoyan J, et al. Irritation Potential and Acute Efficacy of Topically Applied Niagen (Niacinamide Riboside Chloride). Preprints. Posted March 20, 2026. PMID: none. DOI: 10.20944/preprints202603.1657.v1.
checked
Bhasin S, Seals D, Migaud M, Musi N, Baur JA. Nicotinamide Adenine Dinucleotide in Aging Biology: Potential Applications and Many Unknowns. Endocr Rev. 2023;44(6):1047-1073. PMID: 37364580. PMCID: PMC12102727. DOI: 10.1210/endrev/bnad019.
checked
Draft and rewrite: Codex (AI) · Verification: Codex blind grading and adversarial audit · Final adjudication: Claude
Reviewed and approved: Chamgap Editorial Team · Approval date: 2026-07-23 · Corrections: none

Cite this verdict

Topical NAD+ serum x fewer facial wrinkles and improved elasticity and skin aging Evidence Grade ? card
[Chamgap] Topical NAD+ serum x fewer facial wrinkles and improved elasticity and skin aging — Evidence Grade ?. 3 cited sources checked. Source: https://chamgap.com/en/verdicts/antioxidant-aging/topical-nad-serum-facial-wrinkles-elasticity-skin-aging/ · CC BY 4.0

CC BY 4.0 — free to use with attribution; do not distort grades, numbers, or verdict meaning.

!

What this document does and does not do

Chamgap is an information source. It reports what research has and has not confirmed; it does not tell readers what to take or buy. That decision belongs to readers and, when needed, medical or legal professionals. This verdict reflects literature available up to the search date and may change as new research appears. Nothing here is medical advice.